MCRRASLab
@mcrraslab
RAS Research Lab at University of Manchester, led by Dr.Colin Lindsay. Unravelling RAS mutations in cancer. Research driven by patients.#RASResearch #LungCancer
ID: 1677233931253325826
07-07-2023 08:32:13
41 Tweet
48 Takipçi
109 Takip Edilen
🚨COMING TOMORROW🚨 🎙️One in Two Special Episode 🗣️Breast cancer in Black African women with Professor David Wedge: How analysing genomics can improve our understanding of the aggressiveness of breast cancer Stay tuned 👀
Cancer Research UK Manchester Centre is to receive £8.5m boost for clinician scientist training. Cancer Research UK has announced that they are investing a total of £58m at nine research centres, with Manchester set to receive £8.5m.
If you still haven't tuned into our latest #OneinTwo special episode, now is the time ⌚️ Listen to our very own Prof David Wedge speak about 'Breast cancer in Black African women: How genomics analysis can help understanding of aggressiveness' You don't want to miss it 👇
Get ready to explore the ins & outs of forming and managing a multidisciplinary #CancerResearch team with Emma Crosbie. From harnessing diverse expertise to fostering seamless collaboration, join us to learn the secrets behind successful teamwork. The University of Manchester | #AACR24
What is the role of the TME in lung cancer evolution? We are excited to share our new TRACERx paper “Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer” at #AACR24, out in Cancer Discovery today rb.gy/q484j9 Tweetorial👇
Excited to see the poster from Laura Woodhouse on the association between KRAS mutant lung adenocarcinoma and distinct mutational signature profiles. 📌 Stop by section 17 to learn more. The University of Manchester | Manchester Cancer Research Centre | #AACR24
Very proud of The Christie NHS Med Onc trainee Laura Woodhouse MCRRASLab Manchester Cancer Research Centre for winning the AACR-AbbVie Scholar-in-Training Award 🥇 #AACR24
Colin Lindsay presenting a future perspective on non-KRAS G12C mutations in NSCLC at #ESMO24. A top down (clinical) and bottom up (preclinical/translation) approach required for breakthroughs. Exciting time for pan ras / pan KRAS inhibitors @DrColinLindsay MCRRASLab Manchester Cancer Research Centre
#ESMO24 Targeting KRAS in NSCLC🔥 Packed session today on this hot topic: - Current status of KRAS G12Ci #NatashaLeighl - KRAS Non G12C #CollinLindsay - Resistance Mark Awad - KRAS/IO combos Jarushka Naidoo With great questions from KRASKickers #ESMOAmbassadors #ESMO24 ESMO - Eur. Oncology
Science and Innovation at Cancer Research UK Next up - PhD student flash talks! ⭐️Dr Laura Woodhouse is studying the genetic patterns of lung cancer KRAS mutations ⭐️Charlotte Mellor is examining cell death to better treat breast cancer ⭐️Accadius Lunayo is analysing multiomics signatures of oesophageal cancer in Kenya
Exciting to see this work on KRAS signalling in NSCLC published this week! Check it out at link below. Pleased to have contributed to this work during my time in Manchester - congrats to all authors Malliri Lab MCRRASLab William McDaid Martin Baker
Huge congratulations to our UoM colleagues, inc David Wedge on being named 'Highly Cited Researchers' by Clarivate Only 1 in 1,000 researchers achieve this honour—a testament to their incredible influence and impact in their fields! #HighlyCited2024 #ResearchExcellence #UoM